Pfizer
Bill Barberich has extensive work experience with Pfizer. From 2016 to the present (ongoing), they have held the role of Vice President of Operations for Global Sterile Injectables. In this position, they provide leadership for Pfizer's global network of sterile injectable manufacturing sites, with a team of over 14,000 colleagues. Bill is responsible for overseeing the production of over 2 billion sterile doses annually and managing an operating budget of approximately $7 billion.
Prior to their current role, from 2016 to 2018, Bill Barberich served as Vice President of Operations for the Rx Solid Oral Dose product. In this capacity, they led the Solid Oral Dose Pharmaceutical network, which included facilities in various countries and supplied over $20 billion in revenue, primarily driven by the Lipitor, Lyrica, and Eliquis brands.
From 2013 to 2016, Barberich was the Vice President of Operations for Consumer Healthcare at Pfizer. In this role, they provided leadership for the global network of manufacturing sites, producing key brands such as Advil, Centrum, Emergen-C, Nexium, and Thermacare. This network supported $3.5 billion in revenue.
Overall, Barberich's work experience with Pfizer demonstrates their expertise in leading major manufacturing operations across multiple product categories and geographic locations, playing crucial roles in the success of the company.
Bill Barberich received a Bachelor of Science degree in Chemistry from SUNY Geneseo in 1985. Bill then went on to earn another Bachelor of Science degree, this time in Chemical Engineering, from Columbia Engineering in 1987. Bill later pursued a Master of Science degree in Chemical Engineering from Columbia University, which they completed in 1990.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.